Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | JAK3 | P52333 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.30 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.30 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18868357 | 0.89 | ATM (0.47) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL18868254 | 0.88 | KDM4E (0.35) | KDM4EATML3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL22011417 | 0.87 | ATM (0.43) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL18119054 | 0.87 | CYP1A2 (0.38) | KDM4ECYP1A2CYP2C9CYP2C19 | |
| SCHEMBL17300039 | 0.87 | KDM4E (0.37) | KDM4EATML3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL17299668 | 0.87 | KDM4E (0.37) | KDM4EATML3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL17299833 | 0.86 | ATM (0.42) | KDM4EATML3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL18868360 | 0.85 | KDM4E (0.39) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL17299688 | 0.85 | ATM (0.41) | KDM4EATML3MBTL1CYP1A2CYP2C9 | |
| SCHEMBL22186514 | 0.83 | L3MBTL1 (0.44) | KDM4EATML3MBTL1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10319918-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD (KR) | 2019-06-11 | — | — | US | disclosed |
| US-20170352814-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2017-12-07 | — | — | US | disclosed |
| US-20170352814-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2017-12-07 | — | — | US | disclosed |
| US-9768394-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2017-09-19 | — | — | US | disclosed |
| US-9768394-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2017-09-19 | — | — | US | disclosed |
| US-20170141326-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2017-05-18 | — | — | US | disclosed |
| US-20170141326-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2017-05-18 | — | — | US | disclosed |
| WO-2015182994-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2015-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10319918-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | OR10J3, VDAC1, ICOSLG | KDM4E 652/4885ATM 1420/4885L3MBTL1 315/4885 |
| US-20170352814-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OR10J3, VDAC1, ICOSLG | KDM4E 652/4885ATM 1420/4885L3MBTL1 315/4885 |
| US-20170141326-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OR10J3, VDAC1, ICOSLG | KDM4E 652/4885ATM 1420/4885L3MBTL1 315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.